AKT1 and neoplasm: Melanoma is associated with ERK kinase mutations and this is visible in 3%–8% of melanoma cases91 The RAS gene mutation is associated with advancing tumours with poor prognosis and RAS activates MAP‐K/ P13K/Akt demonstrating the significance of the RAS in pathway changes observed in cancers.92